FDA 483 - Stryker Corporation - January 24, 2023
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Stryker Corporation in Portage, MI, a medical device establishment, was cited for two significant issues during an FDA inspection. The firm failed to adequately establish procedures for complaint handling, leading to significant delays in reporting MDRs for the C2 Nerve Monitor device, which was subsequently recalled. Additionally, procedures for design validation, particularly for device software, were found to be inadequately established, with issues in defining software units and executing regression testing.
ID · 48536332-c790-438d-925b-1f1e7e3a30ee